No Data
No Data
FibroGen to Report Third Quarter 2024 Financial Results
FibroGen, Inc. (NASDAQ:FGEN) Not Doing Enough For Some Investors As Its Shares Slump 27%
FibroGen Inc (FGEN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Shifts
Q3 Pharma and Biotech Layoffs in Charts: More Than 1000 Each in July and August
FibroGen Cuts Costs by Terminating San Francisco Lease Early
Express News | FibroGen Inc: Agrees to $10 Million Settlement Amount
No Data
No Data